Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis

Pharmacology and Therapeutics

Volumn 130, Issue 3, 2011, Pages 310-324

  Kang, Nam Joo ^a   Shin, Seung Ho ^b,c   Lee, Hyong Joo ^c   Lee, Ki Won ^b,c  

^a Kyungpook National University   (South Korea)

^b Konkuk University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Carcinogenesis; Chemoprevention; Polyphenol; Signaling cascades

Indexed keywords

3,5,3',4',5' PENTAHYDROXYSTILBENE; 5 DEOXYKAEMPFEROL; 7,3',4' TRIHYDROXYISOFLAVONE; CAFFEIC ACID; CAFFEIC ACID PHENETHYL ESTER; CHLOROGENIC ACID; CURCUMIN; CYANIDIN; DELPHINIDIN; EPIGALLOCATECHIN GALLATE; EQUOL; FISETIN; GENISTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAEMPFEROL; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MYRICETIN; PHOSPHATIDYLINOSITOL 3 KINASE; PICEATANNOL; POLYPHENOL; PROCYANIDIN B2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; QUERCETAGETIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DIETARY INTAKE; DRUG PROTEIN BINDING; ENZYME ACTIVATION; FOOD COMPOSITION; HUMAN; INFLAMMATION; METASTASIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

EID: 79955572744     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.02.004     Document Type: Review

References (148)

1. B.B. Aggarwal, and S. Shishodia Molecular targets of dietary agents for prevention and therapy of cancer Biochem Pharmacol 71 2006 1397 1421
2. B.B. Aggarwal, S. Shishodia, S.K. Sandur, M.K. Pandey, and G. Sethi Inflammation and cancer: How hot is the link? Biochem Pharmacol 72 2006 1605 1621 (Pubitemid 44666739)
3. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, and N. Itoh Genistein, a specific inhibitor of tyrosine-specific protein kinases J Biol Chem 262 1987 5592 5595
4. A. Aleshin, and R.S. Finn SRC: a century of science brought to the clinic Neoplasia 12 2010 599 607
5. J.S. Arthur MSK activation and physiological roles Front Biosci 13 2008 5866 5879
6. L. Bai, S. Xu, W. Chen, Z. Li, X. Wang, and H. Tang Blocking NF-kappaB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death Apoptosis 16 2011 45 54
7. K. Balasubramanyam, R.A. Varier, M. Altaf, V. Swaminathan, N.B. Siddappa, and U. Ranga Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription J Biol Chem 279 2004 51163 51171 (Pubitemid 40017859)
8. A.M. Bode, and Z. Dong Mitogen-activated protein kinase activation in UV-induced signal transduction Sci STKE 2003 RE2
9. F. Bray, and B. Moller Predicting the future burden of cancer Nat Rev Cancer 6 2006 63 74 (Pubitemid 43053652)
10. S. Byun, K.W. Lee, S.K. Jung, E.J. Lee, M.K. Hwang, and S.H. Lim Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer Cancer Res 70 2010 2415 2423
11. G. Cao, R.M. Russell, N. Lischner, and R.L. Prior Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women J Nutr 128 1998 2383 2390 (Pubitemid 29012987)
12. P.A. Cerutti Prooxidant states and tumor promotion Science 227 1985 375 381 (Pubitemid 15153495)
13. M.M. Chan, D. Fong, C.T. Ho, and H.I. Huang Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea Biochem Pharmacol 54 1997 1281 1286 (Pubitemid 27521038)
14. Q. Chang, Y. Zhang, K.J. Beezhold, D. Bhatia, H. Zhao, and J. Chen Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer J Hepatol 50 2009 323 333
15. W.S. Chen, Y.J. Lee, Y.C. Yu, C.H. Hsaio, J.H. Yen, and S.H. Yu Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin Int J Radiat Oncol Biol Phys 77 2010 1527 1535
16. Y.Y. Cho, K. Yao, A. Pugliese, M.L. Malakhova, A.M. Bode, and Z. Dong A regulatory mechanism for RSK2 NH(2)-terminal kinase activity Cancer Res 69 2009 4398 4406
17. S.E. Chow, Y.C. Hshu, J.S. Wang, and J.K. Chen Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages J Appl Physiol 102 2007 1520 1527
18. S. Cowley, H. Paterson, P. Kemp, and C.J. Marshall Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3 T3 cells Cell 77 1994 841 852 (Pubitemid 24187682)
19. P. Csermely, T. Schnaider, C. Soti, Z. Prohaszka, and G. Nardai The 90-kDa molecular chaperone family: Structure, function, and clinical applications A comprehensive review. Pharmacol Ther 79 1998 129 168 (Pubitemid 28380440)
20. M. D'Archivio, C. Filesi, R. Di Benedetto, R. Gargiulo, C. Giovannini, and R. Masella Polyphenols, dietary sources and bioavailability Ann Ist Super Sanita 43 2007 348 361
21. A.S. Dhillon, S. Hagan, O. Rath, and W. Kolch MAP kinase signalling pathways in cancer Oncogene 26 2007 3279 3290 (Pubitemid 46763021)
22. R. Doll, and R. Peto The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today J Natl Cancer Inst 66 1981 1191 1308 (Pubitemid 11063920)
23. Z. Dong, X. Qi, K. Xie, and I.J. Fidler Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages J Immunol 151 1993 2717 2724 (Pubitemid 23264523)
24. M.V. Eberhardt, C.Y. Lee, and R.H. Liu Antioxidant activity of fresh apples Nature 405 2000 903 904 (Pubitemid 30435037)
25. J.A. Engelman Targeting PI3K signalling in cancer: Opportunities, challenges and limitations Nat Rev Cancer 9 2009 550 562
26. J.A. Engelman, J. Luo, and L.C. Cantley The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism Nat Rev Genet 7 2006 606 619 (Pubitemid 44100518)
27. S.P. Ermakova, B.S. Kang, B.Y. Choi, H.S. Choi, T.F. Schuster, and W.Y. Ma (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78 Cancer Res 66 2006 9260 9269 (Pubitemid 44521148)
28. M. Esteller, S.R. Hamilton, P.C. Burger, S.B. Baylin, and J.G. Herman Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Research 59 1999 793 797 (Pubitemid 29086728)
29. M.Z. Fang, Y. Wang, N. Ai, Z. Hou, Y. Sun, and H. Lu Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer Res 63 2003 7563 7570 (Pubitemid 37466673)
30. J. Fang, J. Lu, and A. Holmgren Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity J Biol Chem 280 2005 25284 25290 (Pubitemid 40934623)
31. M.Z. Fang, D. Chen, Y. Sun, Z. Jin, J.K. Christman, and C.S. Yang Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy Clin Cancer Res 11 2005 7033 7041 (Pubitemid 41428763)
32. R. Garcia-Closas, C.A. Gonzalez, A. Agudo, and E. Riboli Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain Cancer Causes Control 10 1999 71 75 (Pubitemid 29134755)
33. T.D. Gilmore Introduction to NF-kappaB: Players, pathways, perspectives Oncogene 25 2006 6680 6684 (Pubitemid 44657845)
34. M. Gururajan, T. Dasu, S. Shahidain, C.D. Jennings, D.A. Robertson, and V.M. Rangnekar Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth J Immunol 178 2007 111 121 (Pubitemid 46033592)
35. S.S. Han, Y.S. Keum, H.J. Seo, and Y.J. Surh Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells J Biochem Mol Biol 35 2002 337 342
36. Z. He, F. Tang, S. Ermakova, M. Li, Q. Zhao, and Y.Y. Cho Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation Mol Carcinog 47 2008 172 183 (Pubitemid 351409338)
37. D. Heber Multitargeted therapy of cancer by ellagitannins Cancer Lett 269 2008 262 268
38. C.G. Heijnen, G.R. Haenen, F.A. van Acker, W.J. van der Vijgh, and A. Bast Flavonoids as peroxynitrite scavengers: The role of the hydroxyl groups Toxicol In Vitro 15 2001 3 6 (Pubitemid 32226368)
39. B.T. Hennessy, D.L. Smith, P.T. Ram, Y. Lu, and G.B. Mills Exploiting the PI3K/AKT pathway for cancer drug discovery Nat Rev Drug Discov 4 2005 988 1004
40. D.X. Hou, K. Kai, J.J. Li, S. Lin, N. Terahara, and M. Wakamatsu Anthocyanidins inhibit activator protein 1 activity and cell transformation: Structure-activity relationship and molecular mechanisms Carcinogenesis 25 2004 29 36 (Pubitemid 38128616)
41. M.K. Hwang, N.R. Song, N.J. Kang, K.W. Lee, and H.J. Lee Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase-9: Its direct inhibition by quercetin Int J Biochem Cell Biol 41 2009 1592 1600
42. M.K. Hwang, N.J. Kang, Y.S. Heo, K.W. Lee, and H.J. Lee Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha Biochem Pharmacol 77 2009 1213 1222
43. R. Ishizawar, and S.J. Parsons c-Src and cooperating partners in human cancer Cancer Cell 6 2004 209 214 (Pubitemid 39222033)
44. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66 (Pubitemid 46148091)
45. C.C. Jiang, Z.G. Mao, K.A. Avery-Kiejda, M. Wade, P. Hersey, and X.D. Zhang Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells Carcinogenesis 30 2009 197 204
46. M.K. Johnson, and G. Loo Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA Mutat Res 459 2000 211 218 (Pubitemid 30254308)
47. S.K. Jung, K.W. Lee, S. Byun, N.J. Kang, S.H. Lim, and Y.S. Heo Myricetin suppresses UVB-induced skin cancer by targeting Fyn Cancer Res 68 2008 6021 6029
48. S.K. Jung, K.W. Lee, S. Byun, E.J. Lee, J.E. Kim, and A.M. Bode Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo Carcinogenesis 31 2010 911 917
49. S.K. Jung, K.W. Lee, H.Y. Kim, M.H. Oh, S. Byun, and S.H. Lim Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf Biochem Pharmacol 79 2010 1455 1461
50. N.J. Kang, K.W. Lee, E.A. Rogozin, Y.Y. Cho, Y.S. Heo, and A.M. Bode Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway J Biol Chem 282 2007 32856 32866 (Pubitemid 350159319)
51. N.J. Kang, K.W. Lee, D.E. Lee, E.A. Rogozin, A.M. Bode, and H.J. Lee Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase J Biol Chem 283 2008 20664 20673
52. N.J. Kang, K.W. Lee, J.Y. Kwon, M.K. Hwang, E.A. Rogozin, and Y.S. Heo Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling Cancer Prev Res (Phila Pa) 1 2008 522 531
53. N.J. Kang, K.W. Lee, B.J. Shin, S.K. Jung, M.K. Hwang, and A.M. Bode Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression Carcinogenesis 30 2009 321 330
54. Kang, N. J., Lee, K. W., Kim, B. H., Bode, A. M., Lee, H. J., Heo, Y. S., et al. (in press). Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis. Epub Feb. 15. 2011, doi:10.1093/carcin/bgr022.
55. D.O. Kim, K.W. Lee, H.J. Lee, and C.Y. Lee Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals J Agric Food Chem 50 2002 3713 3717 (Pubitemid 34640695)
56. J.H. Kim, N.J. Kang, B.K. Lee, K.W. Lee, and H.J. Lee Gallic acid, a metabolite of the antioxidant propyl gallate, inhibits gap junctional intercellular communication via phosphorylation of connexin 43 and extracellular-signal-regulated kinase1/2 in rat liver epithelial cells Mutat Res 638 2008 175 183
57. J.E. Kim, J.Y. Kwon, D.E. Lee, N.J. Kang, Y.S. Heo, and K.W. Lee MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin Biochem Pharmacol 77 2009 412 421
58. J.H. Kim, S.H. Choi, J. Kim, B.K. Lee, K.W. Lee, and H.J. Lee Differential regulation of the hydrogen-peroxide-induced inhibition of gap-junction intercellular communication by resveratrol and butylated hydroxyanisole Mutat Res 671 2009 40 44
59. W.Y. Kim, S.H. Oh, J.K. Woo, W.K. Hong, and H.Y. Lee Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha Cancer Res 69 2009 1624 1632
60. J.E. Kim, J.Y. Kwon, S.K. Seo, J.E. Son, S.K. Jung, and S.Y. Min Cyanidin suppresses ultraviolet B-induced COX-2 expression in epidermal cells by targeting MKK4, MEK1, and Raf-1 Biochem Pharmacol 79 2010 1473 1482
61. P. Knekt, R. Jarvinen, R. Seppanen, M. Hellovaara, L. Teppo, and E. Pukkala Dietary flavonoids and the risk of lung cancer and other malignant neoplasms Am J Epidemiol 146 1997 223 230 (Pubitemid 27329723)
62. P. Knekt, J. Kumpulainen, R. Jarvinen, H. Rissanen, M. Heliovaara, and A. Reunanen Flavonoid intake and risk of chronic diseases Am J Clin Nutr 76 2002 560 568 (Pubitemid 34920833)
63. M.B. Korycka-Dahl, and T. Richardson Activated oxygen species and oxidation of food constituents CRC Crit Rev Food Sci Nutr 10 1978 209 241
64. T. Kumamoto, M. Fujii, and D.X. Hou Myricetin directly targets JAK1 to inhibit cell transformation Cancer Lett 275 2009 17 26
65. J.Y. Kwon, K.W. Lee, J.E. Kim, S.K. Jung, N.J. Kang, and M.K. Hwang Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase Carcinogenesis 30 2009 1932 1940
66. C. La Vecchia, and A. Tavani Fruit and vegetables, and human cancer Eur J Cancer Prev 7 1998 3 8 (Pubitemid 28164130)
67. P.W. Laird Cancer epigenetics Hum Mol Genet 14 2005 R65 R76
68. S. Lamy, R. Lafleur, V. Bedard, A. Moghrabi, S. Barrette, and D. Gingras Anthocyanidins inhibit migration of glioblastoma cells: Structure-activity relationship and involvement of the plasminolytic system J Cell Biochem 100 2007 100 111 (Pubitemid 44958182)
69. V. Lavelli, S. Hippeli, C. Peri, and E.F. Elstner Evaluation of radical scavenging activity of fresh and air-dried tomatoes by three model reactions J Agric Food Chem 47 1999 3826 3831 (Pubitemid 29449513)
70. A.S. Lee GRP78 induction in cancer: therapeutic and prognostic implications Cancer Res 67 2007 3496 3499 (Pubitemid 46762126)
71. K.W. Lee, and H.J. Lee Biphasic effects of dietary antioxidants on oxidative stress-mediated carcinogenesis Mech Ageing Dev 127 2006 424 431
72. K.W. Lee, and H.J. Lee The roles of polyphenols in cancer chemoprevention Biofactors 26 2006 105 121
73. E. Lee, P. Nichols, D. Spicer, S. Groshen, M.C. Yu, and A.S. Lee GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer Cancer Res 66 2006 7849 7853 (Pubitemid 44299145)
74. K.W. Lee, N.J. Kang, E.A. Rogozin, H.G. Kim, Y.Y. Cho, and A.M. Bode Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1 Carcinogenesis 28 2007 1918 1927 (Pubitemid 47500604)
75. K.W. Lee, N.J. Kang, E.A. Rogozin, S.M. Oh, Y.S. Heo, and A. Pugliese The resveratrol analogue 3,5,3′,4′,5′-pentahydroxy-trans-stilbene inhibits cell transformation via MEK Int J Cancer 123 2008 2487 2496
76. K.W. Lee, N.J. Kang, Y.S. Heo, E.A. Rogozin, A. Pugliese, and M.K. Hwang Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine Cancer Res 68 2008 946 955 (Pubitemid 351206774)
77. D.E. Lee, K.W. Lee, N.R. Song, S.K. Seo, Y.S. Heo, and N.J. Kang 7,3′,4′-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase J Biol Chem 285 2010 21458 21466
78. D.E. Lee, B.J. Shin, H.J. Hur, J.H. Kim, J. Kim, and N.J. Kang Quercetin, the active phenolic component in kiwifruit, prevents hydrogen peroxide-induced inhibition of gap-junction intercellular communication Br J Nutr 104 2010 164 170
79. H.H. Lee, S.A. Park, I. Almazari, E.H. Kim, H.K. Na, and Y.J. Surh Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling Arch Biochem Biophys 501 2010 142 150
80. K.M. Lee, D.E. Lee, S.K. Seo, M.K. Hwang, Y.S. Heo, and K.W. Lee Phosphatidylinositol 3-kinase, a novel target molecule for the inhibitory effects of kaempferol on neoplastic cell transformation Carcinogenesis 31 2010 1338 1343
81. K.M. Lee, K.W. Lee, S. Byun, S.K. Jung, S.K. Seo, and Y.S. Heo 5-deoxykaempferol plays a potential therapeutic role by targeting multiple signaling pathways in skin cancer Cancer Prev Res (Phila Pa) 3 2010 454 465
82. K.M. Lee, K.W. Lee, S.K. Jung, E.J. Lee, Y.S. Heo, and A.M. Bode Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity Biochem Pharmacol 80 2010 2042 2049
83. F. Levi Cancer prevention: Epidemiology and perspectives Eur J Cancer 35 1999 1912 1924 (Pubitemid 30026213)
84. J. Li, and A.S. Lee Stress induction of GRP78/BiP and its role in cancer Curr Mol Med 6 2006 45 54
85. X. Li, Y. Yang, Y. Hu, D. Dang, J. Regezi, and B.L. Schmidt Alphavbeta6-Fyn signaling promotes oral cancer progression J Biol Chem 278 2003 41646 41653 (Pubitemid 37310421)
86. M. Li, Z. He, S. Ermakova, D. Zheng, F. Tang, and Y.Y. Cho Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation Cancer Epidemiol Biomarkers Prev 16 2007 598 605 (Pubitemid 46548666)
87. Y.C. Liang, Y.T. Huang, S.H. Tsai, S.Y. Lin-Shiau, C.F. Chen, and J.K. Lin Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages Carcinogenesis 20 1999 1945 1952
88. Y.L. Lin, and J.K. Lin (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB Mol Pharmacol 52 1997 465 472
89. J.K. Lin, P.C. Chen, C.T. Ho, and S.Y. Lin-Shiau Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3′-digallate, (-)-epigallocatechin-3-gallate, and propyl gallate J Agric Food Chem 48 2000 2736 2743
90. P. Liu, H. Cheng, T.M. Roberts, and J.J. Zhao Targeting the phosphoinositide 3-kinase pathway in cancer Nat Rev Drug Discov 8 2009 627 644
91. S.B. Lotito, and B. Frei Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41 2006 1727 1746 (Pubitemid 44839139)
92. H. Lu, D.J. Chang, B. Baratte, L. Meijer, and U. Schulze-Gahmen Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin J Med Chem 48 2005 737 743 (Pubitemid 40209095)
93. J.-L. Luo, H. Kamata, and M. Karin IKK/NF-B signaling: balancing life and death? A new approach to cancer therapy The Journal of Clinical Investigation 115 2005 2625 2632 (Pubitemid 41434385)
94. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: Food sources and bioavailability Am J Clin Nutr 79 2004 727 747 (Pubitemid 41103873)
95. A. Mariotti, P.A. Kedeshian, M. Dans, A.M. Curatola, L. Gagnoux-Palacios, and F.G. Giancotti EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: Role in epithelial cell migration and carcinoma invasion J Cell Biol 155 2001 447 458
96. J. Martinez, and J.J. Moreno Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production Biochem Pharmacol 59 2000 865 870 (Pubitemid 30081710)
97. S. Marubayashi, P. Koppikar, T. Taldone, O. Abdel-Wahab, N. West, and N. Bhagwat HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans J Clin Invest 120 2010 3578 3593
98. T. Masaki, K. Igarashi, M. Tokuda, S. Yukimasa, F. Han, and Y.J. Jin pp 60c-src activation in lung adenocarcinoma Eur J Cancer 39 2003 1447 1455
99. K.H. Miean, and S. Mohamed Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants J Agric Food Chem 49 2001 3106 3112 (Pubitemid 32826116)
100. A. Minden, A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, and R.J. Davis Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK Science 266 1994 1719 1723
101. M. Mutoh, M. Takahashi, K. Fukuda, Y. Matsushima-Hibiya, H. Mutoh, and T. Sugimura Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure Carcinogenesis 21 2000 959 963 (Pubitemid 30265140)
102. K. Natarajan, S. Singh, T.R. Burke Jr., D. Grunberger, and B.B. Aggarwal Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B Proc Natl Acad Sci U S A 93 1996 9090 9095 (Pubitemid 26282023)
103. R.I. Nicholson, J.M.W. Gee, and M.E. Harper EGFR and cancer prognosis Eur J Cancer 37 2001 9 15
104. C. Nishigori, Y. Hattori, and S. Toyokuni Role of reactive oxygen species in skin carcinogenesis Antioxid Redox Signal 6 2004 561 570 (Pubitemid 38625376)
105. M. Noroozi, W.J. Angerson, and M.E. Lean Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes Am J Clin Nutr 67 1998 1210 1218 (Pubitemid 28259509)
106. P.C. Nowell Mechanisms of tumor progression Cancer Res 46 1986 2203 2207 (Pubitemid 16120666)
107. X. Ouyang, W.J. Jessen, H. Al-Ahmadie, A.M. Serio, Y. Lin, and W.J. Shih Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer Cancer Res 68 2008 2132 2144 (Pubitemid 351521785)
108. C.M. Palermo, C.A. Westlake, and T.A. Gasiewicz Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein Biochemistry 44 2005 5041 5052 (Pubitemid 40471220)
109. B.C. Pence, and J.J. Reiners Jr. Murine epidermal xanthine oxidase activity: Correlation with degree of hyperplasia induced by tumor promoters Cancer Res 47 1987 6388 6392 (Pubitemid 18011094)
110. E.M. Perchellet, and J.P. Perchellet Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo Cancer Res 49 1989 6193 6201 (Pubitemid 20000908)
111. S.M. Plummer, K.A. Holloway, M.M. Manson, R.J. Munks, A. Kaptein, and S. Farrow Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex Oncogene 18 1999 6013 6020 (Pubitemid 29535013)
112. P. Rajendran, G. Ekambaram, and D. Sakthisekaran Cytoprotective effect of mangiferin on benzo(a)pyrene-induced lung carcinogenesis in swiss albino mice Basic Clin Pharmacol Toxicol 103 2008 137 142 (Pubitemid 352019725)
113. Y.D. Saito, A.R. Jensen, R. Salgia, and E.M. Posadas Fyn: A novel molecular target in cancer Cancer 116 2010 1629 1637
114. W. Sakamoto, K. Fujie, J. Nishihira, H. Handa, N. Ueda, and S. Yamamoto Effect of vitamin E on expression of cyclooxygenase-2 in lipopolysaccharide- stimulated rat macrophages Biochim Biophys Acta 1304 1996 139 144 (Pubitemid 26414386)
115. T. Sakurai, S. Maeda, L. Chang, and M. Karin Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation Proc Natl Acad Sci U S A 103 2006 10544 10551 (Pubitemid 44078014)
116. S.C. Shen, W.R. Lee, H.Y. Lin, H.C. Huang, C.H. Ko, and L.L. Yang In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production Eur J Pharmacol 446 2002 187 194
117. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev 13 1999 1501 1512 (Pubitemid 29297917)
118. F. Sheu, H.H. Lai, and G.C. Yen Suppression effect of soy isoflavones on nitric oxide production in RAW 264.7 macrophages J Agric Food Chem 49 2001 1767 1772 (Pubitemid 32816817)
119. J.H. Shim, H.S. Choi, A. Pugliese, S.Y. Lee, J.I. Chae, and B.Y. Choi (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase J Biol Chem 283 2008 28370 28379
120. J.H. Shim, Z.Y. Su, J.I. Chae, D.J. Kim, F. Zhu, and W.Y. Ma Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1 Cancer Prev Res (Phila Pa) 3 2010 670 679
121. P.S. Son, S.A. Park, H.K. Na, D.M. Jue, S. Kim, and Y.J. Surh Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-{kappa}B activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKK{beta} as a potential target Carcinogenesis 31 2010 1442 1449
122. M.B. Sporn Carcinogenesis and cancer: Different perspectives on the same disease Cancer Res 51 1991 6215 6218
123. M.B. Sporn, and N. Suh Chemoprevention: An essential approach to controlling cancer Nat Rev Cancer 2 2002 537 543 (Pubitemid 37328935)
124. D.E. Stevenson, and R.D. Hurst Polyphenolic phytochemicals-Just antioxidants or much more? Cell Mol Life Sci 64 2007 2900 2916 (Pubitemid 351152245)
125. K. Subbaramaiah, D. Zakim, B.B. Weksler, and A.J. Dannenberg Inhibition of cyclooxygenase: A novel approach to cancer prevention Proc Soc Exp Biol Med 216 1997 201 210
126. Y.J. Surh Cancer chemoprevention with dietary phytochemicals Nat Rev Cancer 3 2003 768 780
127. Y.J. Surh, K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, and K.K. Park Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation Mutat Res 480-481 2001 243 268 (Pubitemid 32744832)
128. S.M. Thomas, and J.S. Brugge Cellular functions regulated by Src family kinases Annu Rev Cell Dev Biol 13 1997 513 609 (Pubitemid 28034534)
129. A.V. Timoshenko, C. Chakraborty, G.F. Wagner, and P.K. Lala COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer Br J Cancer 94 2006 1154 1163
130. J.E. Trosko, and C.C. Chang Modulation of cell-cell communication in the cause and chemoprevention/chemotherapy of cancer Biofactors 12 2000 259 263 (Pubitemid 32107414)
131. B.L. Upham, K.S. Kang, H.Y. Cho, and J.E. Trosko Hydrogen peroxide inhibits gap junctional intercellular communication in glutathione sufficient but not glutathione deficient cells Carcinogenesis 18 1997 37 42 (Pubitemid 28134614)
132. H. Vainio, and E. Weiderpass Fruit and vegetables in cancer prevention Nutr Cancer 54 2006 111 142 (Pubitemid 44141342)
133. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int J Biochem Cell Biol 39 2007 44 84 (Pubitemid 44566469)
134. K. Vermeulen, D.R. Van Bockstaele, and Z.N. Berneman The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer Cell Proliferation 36 2003 131 149 (Pubitemid 36808270)
135. D.J. Wadleigh, S.T. Reddy, E. Kopp, S. Ghosh, and H.R. Herschman Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages J Biol Chem 275 2000 6259 6266 (Pubitemid 30129916)
136. E.F. Wagner, and A.R. Nebreda Signal integration by JNK and p38 MAPK pathways in cancer development Nat Rev Cancer 9 2009 537 549
137. A.L. Waterhouse Wine phenolics Ann N Y Acad Sci 957 2002 21 36 (Pubitemid 34721651)
138. L.W. Wattenberg Chemoprevention of cancer Cancer Res 45 1985 1 8 (Pubitemid 15196921)
139. H. Wei, R. Bowen, Q. Cai, S. Barnes, and Y. Wang Antioxidant and antipromotional effects of the soybean isoflavone genistein Proc Soc Exp Biol Med 208 1995 124 130
140. C. Whibley, P.D. Pharoah, and M. Hollstein p53 Polymorphisms: Cancer implications Nat Rev Cancer 9 2009 95 107
141. H. Wiseman, and B. Halliwell Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer Biochem J 313 Pt 1 1996 17 29 (Pubitemid 26013419)
142. K. Xu, and H.K. Shu EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas Cancer Res 67 2007 6121 6129 (Pubitemid 47037492)
143. S. Yang, K. Irani, S.E. Heffron, F. Jurnak, and F.L. Meyskens Jr. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor Mol Cancer Ther 4 2005 1923 1935 (Pubitemid 43056975)
144. M. Yang, S.I. Koo, W.O. Song, and O.K. Chun Food matrix affecting anthocyanin bioavailability: Review Curr Med Chem 18 2011 291 300
145. Y. Yarden The EGFR family and its ligands in human cancer: Signalling mechanisms and therapeutic opportunities Eur J Cancer 37 2001 3 8
146. T. Zarubin, and J. Han Activation and signaling of the p38 MAP kinase pathway Cell Res 15 2005 11 18 (Pubitemid 41653958)
147. L.H. Zhang, and X. Zhang Roles of GRP78 in physiology and cancer J Cell Biochem 110 2010 1299 1305
148. T.A. Zykova, F. Zhu, X. Zhai, W.Y. Ma, S.P. Ermakova, and K.W. Lee Resveratrol directly targets COX-2 to inhibit carcinogenesis Mol Carcinog 47 2008 797 805